Pavel I Makarevich
Overview
Explore the profile of Pavel I Makarevich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makarevich P, Tkachuk V
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519061
As regenerative medicine continues to advance as a growing field in modern biology and the healthcare industry, it attracts enormous interest from the general public and scientists [...].
2.
Vakhrushev I, Basok Y, Baskaev K, Novikova V, Leonov G, Grigoriev A, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38891883
Articular cartilage damage still remains a major problem in orthopedical surgery. The development of tissue engineering techniques such as autologous chondrocyte implantation is a promising way to improve clinical outcomes....
3.
Gabashvili A, Alexandrushkina N, Mochalova E, Goliusova D, Sapozhnikova E, Makarevich P, et al.
Exp Biol Med (Maywood)
. 2024 May;
249:10055.
PMID: 38774281
Currently, various functionalized nanocarrier systems are extensively studied for targeted delivery of drugs, peptides, and nucleic acids. Joining the approaches of genetic and chemical engineering may produce novel carriers for...
4.
Glazieva V, Alexandrushkina N, Nimiritsky P, Kulebyakina M, Eremichev R, Makarevich P
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069373
Cell sheet (CS) engineering using mesenchymal stromal cells (MSC) draws significant interest for regenerative medicine and this approach translates to clinical use for numerous indications. However, little is known of...
5.
Stafeev I I, Boldyreva M, Michurina S, Agareva M, Radnaeva A, Menshikov M, et al.
Cells
. 2022 Dec;
11(23).
PMID: 36497083
Background: Combined non-viral gene therapy (GT) of ischemia and cardiovascular disease is a promising tool for potential clinical translation. In previous studies our group has developed combined gene therapy by...
6.
7.
Kulebyakin K, Nimiritsky P, Makarevich P
Front Endocrinol (Lausanne)
. 2020 Aug;
11:384.
PMID: 32733378
The potential rapid advance of regenerative medicine was obstructed by findings that stimulation of human body regeneration is a much tougher mission than expected after the first cultures of stem...
8.
Boldyreva M, Shevchenko E, Molokotina Y, Makarevich P, Beloglazova I, Zubkova E, et al.
Int J Mol Sci
. 2019 Jun;
20(12).
PMID: 31238604
Cell therapy remains a promising approach for the treatment of cardiovascular diseases. In this regard, the contemporary trend is the development of methods to overcome low cell viability and enhance...
9.
Nimiritsky P, Eremichev R, Alexandrushkina N, Efimenko A, Tkachuk V, Makarevich P
Int J Mol Sci
. 2019 Feb;
20(4).
PMID: 30769851
Regeneration is a fundamental process attributed to the functions of adult stem cells. In the last decades, delivery of suspended adult stem cells is widely adopted in regenerative medicine as...
10.
Dyikanov D, Vasiluev P, Rysenkova K, Aleksandrushkina N, Tyurin-Kuzmin P, Kulebyakin K, et al.
Tissue Eng Part C Methods
. 2019 Feb;
25(3):168-175.
PMID: 30747044
Cell lines represent convenient models to elucidate specific causes of multigenetic and pluricausal diseases, to test breakthrough regenerative technologies. Most commonly used cell lines surpass diploid cells in their accessibility...